Hans Törnblom1, Richard Goosey2, Gwen Wiseman3, Stephen Baker4, Anton Emmanuel5. 1. Department of Internal Medicine & Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 2. Kantar Health, Epsom, UK. 3. (formerly) Allergan plc, Marlow, UK. 4. Allergan plc, Marlow, UK. 5. University College Hospital, London, UK.
Abstract
BACKGROUND: Irritable bowel syndrome with diarrhoea (IBS-D) comprises multiple troublesome symptoms and negatively impacts patients' quality of life. OBJECTIVE: The objective of this article is to assess IBS-D patient burden and patient and healthcare professional (HCP) attitudes towards IBS. METHODS: Patients and HCPs from Australia, Canada, France, Germany, Italy, Spain and the United Kingdom completed internet-based surveys via market research panels. Attitudes to IBS-D-related statements were scored using seven-point Likert scales. RESULTS: The patient survey included 513 patients (70% female, mean age 40.9 years). Faecal urgency was reported as the most troublesome symptom (27%) and fatigue occurred on the most days per month (mean: 18); 61% of patients used ≥3 types of treatment daily or intermittently; 19% used antidepressants daily. Thirty-three per cent thought HCPs should listen and provide more support and 46% reported willingness to 'try anything' to help manage their IBS-D. The HCP survey included 366 primary care physicians and 313 gastroenterologists: A total of 70% and 65%, respectively, agreed it was important that IBS-D patients feel listened to and supported; 73% agreed their main aim was to improve quality of life; ∼30% expressed frustration at managing IBS-D. CONCLUSION: IBS-D imposes a substantial burden on patients and HCPs. These findings point towards a need for improved patient-HCP communication.
BACKGROUND: Irritable bowel syndrome with diarrhoea (IBS-D) comprises multiple troublesome symptoms and negatively impacts patients' quality of life. OBJECTIVE: The objective of this article is to assess IBS-D patient burden and patient and healthcare professional (HCP) attitudes towards IBS. METHODS: Patients and HCPs from Australia, Canada, France, Germany, Italy, Spain and the United Kingdom completed internet-based surveys via market research panels. Attitudes to IBS-D-related statements were scored using seven-point Likert scales. RESULTS: The patient survey included 513 patients (70% female, mean age 40.9 years). Faecal urgency was reported as the most troublesome symptom (27%) and fatigue occurred on the most days per month (mean: 18); 61% of patients used ≥3 types of treatment daily or intermittently; 19% used antidepressants daily. Thirty-three per cent thought HCPs should listen and provide more support and 46% reported willingness to 'try anything' to help manage their IBS-D. The HCP survey included 366 primary care physicians and 313 gastroenterologists: A total of 70% and 65%, respectively, agreed it was important that IBS-D patients feel listened to and supported; 73% agreed their main aim was to improve quality of life; ∼30% expressed frustration at managing IBS-D. CONCLUSION: IBS-D imposes a substantial burden on patients and HCPs. These findings point towards a need for improved patient-HCP communication.
Authors: Brian E Lacy; Justin Rosemore; Douglas Robertson; David A Corbin; Maria Grau; Michael D Crowell Journal: Scand J Gastroenterol Date: 2006-08 Impact factor: 2.423
Authors: Eamonn M M Quigley; Michael Fried; Kok-Ann Gwee; Igor Khalif; A P S Hungin; Greger Lindberg; Zaigham Abbas; Luis B Fernandez; Shobna J Bhatia; Max Schmulson; Carolina Olano; Anton LeMair Journal: J Clin Gastroenterol Date: 2016-10 Impact factor: 3.062
Authors: Douglas A Drossman; Carolyn Blank Morris; Susan Schneck; Yuming J B Hu; Nancy J Norton; William F Norton; Stephan R Weinland; Christine Dalton; Jane Leserman; Shrikant I Bangdiwala Journal: J Clin Gastroenterol Date: 2009-07 Impact factor: 3.062
Authors: Elaine F Harkness; Val Harrington; Sue Hinder; Sarah J O'Brien; David G Thompson; Paula Beech; Carolyn A Chew-Graham Journal: BMC Fam Pract Date: 2013-06-27 Impact factor: 2.497
Authors: Navkiran T Tornkvist; Imran Aziz; William E Whitehead; Ami D Sperber; Olafur S Palsson; Jóhann Pall Hreinsson; Magnus Simrén; Hans Törnblom Journal: United European Gastroenterol J Date: 2021-10-01 Impact factor: 4.623
Authors: Christopher V Almario; Samuel Eberlein; Carine Khalil; Brennan M R Spiegel Journal: Neurogastroenterol Motil Date: 2021-04-02 Impact factor: 3.598
Authors: Anton Emmanuel; Richard William Goosey; Gwen Wiseman; Stephen Baker; Hans Törnblom Journal: BMC Gastroenterol Date: 2020-04-26 Impact factor: 3.067